440 related articles for article (PubMed ID: 15241610)
1. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
[TBL] [Abstract][Full Text] [Related]
4. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
5. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Toris CB; Camras CB; Yablonski ME
Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
[TBL] [Abstract][Full Text] [Related]
6. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MV; Camras CB
J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
[TBL] [Abstract][Full Text] [Related]
7. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
8. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
9. Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients.
Kondo N; Sawada A; Yamamoto T; Taniguchi T
Jpn J Ophthalmol; 2006; 50(1):20-4. PubMed ID: 16453183
[TBL] [Abstract][Full Text] [Related]
10. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
Ziai N; Dolan JW; Kacere RD; Brubaker RF
Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
12. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
13. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
Saito M; Takano R; Shirato S
Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
Christiansen GA; Nau CB; McLaren JW; Johnson DH
Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
[TBL] [Abstract][Full Text] [Related]
15. Effects of brimonidine on aqueous humor dynamics in human eyes.
Toris CB; Gleason ML; Camras CB; Yablonski ME
Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanism for the additivity of pilocarpine and latanoprost.
Toris CB; Zhan GL; Zhao J; Camras CB; Yablonski ME
Am J Ophthalmol; 2001 Jun; 131(6):722-8. PubMed ID: 11384567
[TBL] [Abstract][Full Text] [Related]
17. Effects of apraclonidine on aqueous humor dynamics in human eyes.
Toris CB; Tafoya ME; Camras CB; Yablonski ME
Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
[TBL] [Abstract][Full Text] [Related]
19. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study.
Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T
Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
Serle JB; Podos SM; Kitazawa Y; Wang RF
Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]